(RECORDING) ANCILLARY SYMPOSIUM - BREAKING BAD: REDUCING GLUCOSE VARIABILITY AND INCREASING TIME IN RANGE IN PATIENTS WITH DIABETES
This program will feature informative sessions directed by key opinion leaders who will discuss different aspects of diabetes technology from the scientific basis to the clinical integration of diabetes technology and time in range in their day to day practice. A case workshop will follow the educational series where challenging, real clinical cases will be provided to the attendees and attendees will answer the case questions through the Audience Response System (ARS). Following each case, the expert faculty presenters will discuss their approach to the cases. This symposium is certified for 1.5 AMA PRA Category 1 Credits™ and 1.5 ABIM MOC points.
This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals.
Upon completion of this educational activity, learners will be able to:
- Explain and interpret current guidelines, consensus statements, and playbooks on time in range
- Discuss and evaluate strategies for the optimal use of diabetes technology in practice
- Value the significance of glucose variability and how to assess it
Steven Edelman, MD- Program Chair
Professor of Medicine
University of California San Diego
Veterans Affairs Medical Center
San Diego, CA
Jeremy Pettus, MD
Assistant Professor of Medicine
University of California San Diego
San Diego, CA
Rayhan A. Lal, MD
Stanford University Medical Center
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships during the content development process for this activity:
- Steven Edelman, MD: Advisory Board Member, AstraZeneca, BrightSight, Ipsen, Lexicon Pharmaceuticals, Inc., Novo Nordisk, Inc., Senseonics; Speaker, Lilly USA, Inc., MannKind Corporation, Merck, Sanofi-Aventis
- Jeremy Pettus, MD: Consulting, Sanofi, Novo Nordisk, Inc., MannKind Corporation, Lexicon Pharmaceuticals, Inc.
- Rayhan A. Lal, MD: Consulting, Abbott Diabetes Care, Biolinq, Capillary Biomedical, Tidepool
The following Special Programs Committee member who planned and reviewed content for this activity reported relevant financial relationships:
- Andjela T. Drincic, MD: Advisory Board Member, Corcept
The following Special Programs Committee members reported financial relationships:
- Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca
- Steven T. Harris, MD: Ad hoc consultant on Advisory Boards, Eli Lilly & Company, Radius Health; Speaker, Amgen, Eli Lilly & Company, Radius Health
- Angela M. Leung, MD: Speaker,Medical Education Resources, MCE Conferences
- Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck
The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.
The following Special Programs Committee members reported no relevant financial relationships:
- Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD, Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™ and 1.5 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification (MOC) Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to: 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact.
- 1.50 MOC
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation
This course is offered through Endocrine Society. To take this course you will be redirected to Endocrine Society's website. You must have an account with Endocrine Society in order to complete this activity.
Mocingbird continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!